Indonesia's developed Covid 19 Vaccines will be used in October 2022

[Indos]

BPOM Calls Red and White Vaccine Emergency Use Permit Out in Early October​

BPOM Chairman, Penny K Lukito

28 September 2022


JAKARTA, KOMPAS.com - Head of the Food and Drug Supervisory Agency (BPOM) Penny K Lukito revealed that the Red and White Vaccine will soon get an emergency use authorization (EUA).

"So it's a little while. It's September. In early October, we will get emergency use authorization," penny said at the Senayan Parliament Complex, Jakarta, Wednesday (28/9/2022).

Penny said, the Red and White Vaccine is also a vaccine that is halal certified.

In addition to the Red and White vaccine, other vaccines such as Ethane and mRNA are also kosher.

"So all domestic vaccines are kosher vaccines. Including the Ethane ones, which are mRNA, which is also halal," she said.

"So the latest technology that is mRNA and halal is in Indonesia," she continued.

Furthermore, she also revealed that the Indovac vaccine has received an EUA.

Also read: The Red and White Vaccine Officially Becomes Inavac, Khofifah: Indonesia Should Be Proud

Thus, PT Bio Farma was also declared ready to produce the vaccine in Indonesia.

Previously reported, two domestically produced vaccines, Inavac and Indovac are now in late-stage clinical trials by BPOM.

Penny hopes the vaccine's distribution permit or emergency use authorization is out. These two types of vaccines have also been approved by President Joko Widodo.

Also read: Members of the House of Representatives Hope the Red and White Vaccine and Bio Farma Are Launched On August 17

"Domestic vaccines, namely the Red and White Unair vaccine, Biotis, and Bio Farma Vaccine, Baylor, namely the Inavac and Indovac vaccines in their development, have entered phase III clinical trials, this is in progress," penny said as quoted from the YouTube show commission IX DPR RI, Wednesday (31/8/2022).

"Hopefully, the hope is that this September, the EUA can be issued. So it's already in the final stages," Penny continued.

Also read: Phase 3 Clinical Trial of Red and White Vaccine Assessed as a Breakthrough in Indonesia's Health Security

Penny revealed that these two types of domestically made vaccines are also proposed to be booster doses and primary vaccinations for children. Both are now in the process of applying for clinical trial protocols.

MSN

 

[Indos]

Nation’s first homegrown Covid-19 vaccine launched​

• INDONESIA
• Saturday, 15 Oct 2022

The country’s leader has launched the country’s first home-grown Covid-19 shot to help reduce the world’s fourth most populous nation’s dependency on imported vaccines.

President Joko Widodo on Thursday announced the vaccine brand, IndoVac, as a new milestone of Indonesia’s pharmaceutical industry that will manufacture primary series vaccines, booster vaccines and vaccines for children, which have been in development since November 2021.

“From now on, we can produce our own Covid-19 vaccine,” Joko said in an unveiling ceremony in West Java’s Bandung city.
“And so we have independence in vaccine matters.”

During the ceremony, 15 residents who had not received any Covid-19 vaccine got their first IndoVac jabs.

Indonesia’s Food and Drug Authority greenlighted emergency use authorisation of IndoVac in September, with an efficacy above 80% after two shots.

The vaccine passed an audit by the country’s highest Islamic body that the shot is fit for consumption by Muslims – a particularly important factor in the world’s most populous Muslim nation.

IndoVac, made by inserting the genetic code for the antigen into yeast cells, is developed by state-owned pharmaceutical company Bio Farma in collaboration with US-based Baylor College of Medicine, a private, independent health sciences centre in Houston, Texas.

Joko said Bio Farma plans to produce 20 million doses of primary series vaccine this year and 40 million doses next year as the company expands its facilities.

In 2024, production may further increase to 120 million doses per year, depending on demand and the market.

As of Thursday, 73% of Indonesia’s 234.6 million people eligible for shots were fully two-dose vaccinated, and about 27% had had a first booster dose. — AP

Nation’s first homegrown Covid-19 vaccine launched

The country’s leader has launched the country’s first home-grown Covid-19 shot to help reduce the world’s fourth most populous nation’s dependency on imported vaccines.

www.thestar.com.my

 

[Indos]

October 8, 202212:37 AM GMT+7Last Updated 7 days ago

Indonesia in talks with African countries to export its homemade COVID shot​

By Stanley Widianto
and Kate Lamb

JAKARTA, Oct 7 (Reuters) - Indonesia is in talks with several African countries, including Nigeria, to export and donate its homemade COVID-19 vaccine, its developer said on Friday, after becoming the first country in Southeast Asia to approve a domestically developed COVID shot.

Reporting by Stanley Widianto and Kate Lamb in Sydney; Editing by Miyoung Kim

Indonesia in talks with African countries to export its homemade COVID shot

Indonesia is in talks with several African countries, including Nigeria, to export and donate its homemade COVID-19 vaccine, its developer said on Friday, after becoming the first country in Southeast Asia to approve a domestically developed COVID shot.

www.reuters.com

 

[Indos]

Second home grown Covid Vaccine made in and by South East Asian researchers/company are still Indonesian made, Inavac

---------------------------------------------------------------------

1 minute readNovember 4, 20224:13 PM GMT+7Last Updated 2 days ago

Indonesia gives emergency use approval to home-grown COVID-19 vaccine Inavac​

Reuters
JAKARTA, Nov 4 (Reuters) - Indonesia has approved its home-grown coronavirus vaccine Inavac for emergency use, its food and drug agency said on Friday.

Reporting by Stanley Widianto; Editing by Martin Petty

Indonesia gives emergency use approval to home-grown COVID-19 vaccine Inavac

Indonesia has approved its home-grown coronavirus vaccine Inavac for emergency use, its food and drug agency said on Friday.

www.reuters.com

 

[Indos]

Indonesian authority approves home-made Inavac as Covid-19 vaccine​

JAKARTA, Nov 5 (Xinhua): Indonesia's food and drug authority BPOM has approved the emergency use authorisation for the Inavac Covid-19 vaccine as primary for the age group of 18 years and above.

"Considering security aspects and efficacy, the Inavac vaccine has been approved for active immunization for Covid-19 prevention in individuals aged 18 years and above," BPOM chief Penny K. Lukito told a virtual press conference on Friday.

Inavac is an inactivated virus platform vaccine researched by the campus in the second-largest city of Surabaya, Airlangga University, and produced by PT. Biotis Pharmaceutical Indonesia.

Covid-19 transmission in the archipelagic country has risen in recent weeks, with the latest cases on Friday night (Nov 4) at 5,303, bringing the total to 6,512,913. - Xinhua

Indonesian authority approves home-made Inavac as Covid-19 vaccine

Indonesia's food and drug authority BPOM has approved the emergency use authorisation for the Inavac Covid-19 vaccine as primary for the age group of 18 years and above.

www.thestar.com.my